Endocrine disorders of sodium regulation - Role of adrenal steroids in genetic defects causing sodium loss or sodium retention

被引:12
作者
Kuhnle, U
Lewicka, S
Fuller, PJ
机构
[1] Ctr Child & Adolescent Hlth, DE-82131 Munich, Germany
[2] Heidelberg Univ, Inst Pharmakol, D-6900 Heidelberg, Germany
[3] Prince Henrys Inst Med Res, Clayton, Vic, Australia
关键词
adrenal steroids; genetics; sodium homoeostasis;
D O I
10.1159/000075242
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Salt and water homoeostasis is tightly regulated by a variety of control mechanisms with the adrenal steroid hormone aldosterone playing a central role. Defects or disturbances in these systems lead to either salt loss, which is life threatening in the neonatal period, or sodium retention causing hypertension. Rapid and accurate diagnosis is required to avoid severe complications. During the last few years molecular genetic advances have been identified as the basic genetic defects for a number of clinical syndromes. This knowledge has considerably increased our understanding of the basic pathways involved in sodium and water homoeostasis and of the pathophysiology of these syndromes, particularly the hypertension. In this review we have summarized the biochemical, physiological and genetic basis for clinical syndromes presenting with salt loss and failure to thrive as well as the rare but important genetic syndromes causing sodium retention and hypertension. Early diagnosis and identification will help to prevent severe complications, but it has to be emphasized that the complicated cascade of aldosterone action is still relatively poorly understood. Further syndromes may exist which once identified will help to better understand the basic physiology of aldosterone action. Copyright (C) 2004 S. Karger AG, Basel.
引用
收藏
页码:68 / 83
页数:16
相关论文
共 98 条
[1]   A mutation in the gene encoding steroidogenic factor-1 causes XY sex reversal and adrenal failure in humans [J].
Achermann, JC ;
Ito, M ;
Ito, M ;
Hindmarsh, PC ;
Jameson, JL .
NATURE GENETICS, 1999, 22 (02) :125-126
[2]   Mechanisms of disease - Ion channels - Basic science and clinical disease [J].
Ackerman, MJ ;
Clapham, DE .
NEW ENGLAND JOURNAL OF MEDICINE, 1997, 336 (22) :1575-1586
[3]   Primary care -: Hypernatremia [J].
Adrogué, HJ ;
Madias, NE .
NEW ENGLAND JOURNAL OF MEDICINE, 2000, 342 (20) :1493-1499
[4]   Primary care:: Hyponatremia. [J].
Adrogué, HJ ;
Madias, NE .
NEW ENGLAND JOURNAL OF MEDICINE, 2000, 342 (21) :1581-1589
[5]   Role of 11β-hydroxysteroid dehydrogenase in nongenomic aldosterone effects in human arteries [J].
Alzamora, R ;
Michea, L ;
Marusic, ET .
HYPERTENSION, 2000, 35 (05) :1099-1104
[6]   Polymorphisms of amiloride-sensitive sodium channel subunits in five sporadic cases of pseudohypoaldosteronism: Do they have pathologic potential? [J].
Arai, K ;
Zachman, K ;
Shibasaki, T ;
Chrousos, GP .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1999, 84 (07) :2434-2437
[7]   A CORTICOSTEROID-INDUCED GENE EXPRESSING AN ISK-LIKE K+ CHANNEL ACTIVITY IN XENOPUS OOCYTES [J].
ATTALI, B ;
LATTER, H ;
RACHAMIM, N ;
GARTY, H .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (13) :6092-6096
[8]   CHIF, a member of the FXYD protein family, is a regulator of Na,K-ATPase distinct from the γ-subunit [J].
Béguin, P ;
Crambert, G ;
Guennoun, S ;
Garty, H ;
Horisberger, JD ;
Geering, K .
EMBO JOURNAL, 2001, 20 (15) :3993-4002
[9]   Mineralocorticoid receptor knockout mice:: Pathophysiology of Na+ metabolism [J].
Berger, S ;
Bleich, M ;
Schmid, W ;
Cole, TJ ;
Peters, J ;
Watanabe, H ;
Kriz, W ;
Warth, R ;
Greger, R ;
Schütz, G .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (16) :9424-9429
[10]   The serum- and glucocorticoid-induced kinase is a physiological mediator of aldosterone action [J].
Bhargava, A ;
Fullerton, MJ ;
Myles, K ;
Purdy, TM ;
Funder, JW ;
Pearce, D ;
Cole, TJ .
ENDOCRINOLOGY, 2001, 142 (04) :1587-1594